For release: 07:00, 18 September 2025
EMV Capital plc
("EMVC" or the "Company")
Notice of Interim Results and Investor Presentation
EMV Capital plc (AIM: EMVC), the deeptech and life sciences VC investment group, announces that its Interim Results for the six months ended 30 June 2025 will be released on 30 September 2025.
Analyst and Investor Presentation
A live results meeting will be held online on the Investor Meet Company platform on Tuesday 30 September 2025 at 10.00 BST. This presentation is open to all interested parties. Anyone can sign up for free to the Investor Meet Company platform and join the live presentation via:
https://www.investormeetcompany.com/emv-capital-plc/register-investor
Those who already follow the Company on the Investor Meet Company platform will automatically be invited.
Questions can be submitted pre-event via your Investor Meet Company dashboard up until 29 Sept 2025, 09:00 BST, or at any time during the live presentation.
-Ends-
For more information, please contact:
|
|
|
| EMV Capital plc |
via Rosewood |
|
Ilian Iliev, CEO |
|
|
|
|
| Panmure Liberum Limited (NOMAD and Broker) |
+44 (0)20 7886 2500 |
|
Emma Earl / Will Goode / Freddy Crossley / Mark Rogers (Corporate Finance) |
|
|
Rupert Dearden (Corporate Broking) |
|
|
|
|
| Rosewood (Financial PR) |
+44 (0)20 7653 8702 |
| John West / Llewellyn Angus / Lily Pearce |
|
About EMV Capital plc (EMVC)
EMV Capital plc, is a deep tech and life sciences venture capital investment group with an international portfolio of high-growth companies.
With a strategic focus on generating superior returns for investors from the fast-growing sectors and technologies that will define our future; EMV Capital invests in, manages and strengthens early-stage IP-rich companies.
EMV Capital holds both direct equity stakes and carried interest in its portfolio companies, creating an evergreen structure that supports extensive growth and value creation. EMV Capital's investment thesis is realised through these capital sources:
· capital-efficient investments through Group balance sheet;
· fund management of the Evergreen EIS and Martlet Capital Funds;
· syndicated investments leveraging its network of third-party investors.
EMV Capital's approach is characterised by its proactive management style, aiming to advance portfolio companies to critical value inflection points by actively engaging with them. Companies are supported through Board representation and the use of its Value Creation Services practice.
Headquartered in London, with a Cambridge presence and strong international links, EMV Capital is quoted on the AIM market of the London Stock Exchange.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.